Victoria Nachar (@victorianachar) 's Twitter Profile
Victoria Nachar

@victorianachar

Hematology Clinical Pharmacist @UMRogelCancer 〽️#GoBills #Buffalove

ID: 326455500

calendar_today29-06-2011 23:13:35

1,1K Tweet

452 Followers

275 Following

Bernie Marini (@berninini) 's Twitter Profile Photo

I’m excited to introduce our brand new hematology podcast – WolverHeme Happy Hour (@wolverheme anchor.fm/wolverheme)! Grab your favorite drink🍻and listen to me, Anthony Perissinotti, and friends nerd out about heme data! open.spotify.com/show/3VDDwc3BE… #TwitteRx #WolverHeme

WolverHeme (@wolverheme) 's Twitter Profile Photo

Episode 9: "ASH Recap Part 1 - Dauno-Double Trouble" is out! Should this trial change practice? Is Dauno 90 really dead? Our discussion might surprise you! #leusm #twitterx #teambadblood Bernie Marini Anthony Perissinotti anchor.fm/wolverheme/epi…

WolverHeme (@wolverheme) 's Twitter Profile Photo

Swipe right, and listen to Episode 12 "Tinder for T Cells - Bispecifics in DLBCL" by WolverHeme Happy Hour. We are joined by special guest Lymphoma Experts Victoria Nachar and Tycel Phillips! Bernie Marini Anthony Perissinotti anchor.fm/wolverheme/epi…

ProCE (@procehealth) 's Twitter Profile Photo

Managed care professionals looking to stay updated on the latest in #myelofibrosiscare. Join our CPE-certified webinar with Victoria Nachar, Justin Arnall. Learn about treatment advances & pharmacist roles in patient care. 👉 Add it to your calendar: proce.com/events/pharmac…

Managed care professionals looking to stay updated on the latest in #myelofibrosiscare. Join our CPE-certified webinar with <a href="/VictoriaNachar/">Victoria Nachar</a>, <a href="/JustinArnall1/">Justin Arnall</a>. Learn about treatment advances &amp; pharmacist roles in patient care.

👉 Add it to your calendar: proce.com/events/pharmac…
WolverHeme (@wolverheme) 's Twitter Profile Photo

Check out our latest episode "Myeloma Madness with the Myeloma Man", where Anthony Perissinotti and Bernie Marini discuss the recent FDA approval updates on CAR-T in myeloma with our good friend and myeloma expert Manni Mohyuddin podcasters.spotify.com/pod/show/wolve…

Zahra M, PharmD, MBA, BCOP, FHOPA (@kczmj) 's Twitter Profile Photo

Bispecific antibodies are changing treatment in Hem/Onc.. but adoption has been mixed due to logistics! Out now in JADPRO, we aim to tackle some FAQ! 🙏🏻 to Amir Ali, PharmD, BCOP James Davis, PharmD, BCOP Tyler Sandahl Victoria Nachar Robert Mancini, PharmD, BCOP, FHOPA! #oncopharm #TwitterRx jadpro.com/online-first/2…

WolverHeme (@wolverheme) 's Twitter Profile Photo

Time for a MANTLE CELL MASTERCLASS with Tycel Phillips Anthony Perissinotti and Bernie Marini ! Should TRIANGLE change the SOC? Where do bispecifics and CAR-T fit into the treatment paradigm? Listen and find out! #lymsm #twitterx podcasters.spotify.com/pod/show/wolve…

James Davis, PharmD, BCOP (@thisisjamesd) 's Twitter Profile Photo

How do you treat low grade CRS due to myeloma bispecifics? We investigated differences of using dexamethasone and toci in CRS with teclistamab in six US centers and found as few as one 10mg dex dose is enough to alleviate low grade CRS. #ASH24 Victoria Nachar Zahra M, PharmD, MBA, BCOP, FHOPA Jordan Snyder

How do you treat low grade CRS due to myeloma bispecifics? We investigated differences of using dexamethasone and toci in CRS with teclistamab in six US centers and found as few as one 10mg dex dose is enough to alleviate low grade CRS. #ASH24 <a href="/VictoriaNachar/">Victoria Nachar</a> <a href="/kczmj/">Zahra M, PharmD, MBA, BCOP, FHOPA</a> <a href="/j_snyder0132/">Jordan Snyder</a>
HOPARX (@hoparx) 's Twitter Profile Photo

HOPA's OCC, with the participation of ASCO Quality Training Programs, has developed practice-based tools to aid in developing and improving initiatives and the care of patients receiving oral anticancer agents (OAAs). Read the full article Journal of Clinical Oncology: bit.ly/40YzPiV

HOPA's OCC, with the participation of <a href="/ASCO/">ASCO</a> Quality Training Programs, has developed practice-based tools to aid in developing and improving initiatives and the care of patients receiving oral anticancer agents (OAAs). Read the full article <a href="/JCO_ASCO/">Journal of Clinical Oncology</a>: bit.ly/40YzPiV
OncoDaily (@oncodaily) 's Twitter Profile Photo

Myeloma Paper of the Day, March 5th, suggested by Robert Orlowski (Robert Z. Orlowski) Victoria Nachar Zahra M, PharmD, MBA, BCOP, FHOPA oncodaily.com/science/myelom… #MyelomaPaperoftheDay #OncoDaily #Oncology #Cancer #Health #Medicine #MedTwitter #MedEd #MedOnc #MedNews

Medscape Pharmacists (@medscapepharm) 's Twitter Profile Photo

📘 Dive into BCMA-directed therapies for MM and strengthen your treatment approach with new data! 📍 Oregon Convention Center, 777 NE Martin Luther King Jr Blvd, Room B113-114 📢 Learn more: ms.spr.ly/6016qSSUy Join 👉 Kirollos Hanna Victoria Nachar Jared Matya #HOPA2025

📘 Dive into BCMA-directed therapies for MM and strengthen your treatment approach with new data!  
📍 Oregon Convention Center, 777 NE Martin Luther King Jr Blvd, Room B113-114  
📢 Learn more: ms.spr.ly/6016qSSUy
Join 👉 <a href="/KirollosPharmD/">Kirollos Hanna</a> <a href="/VictoriaNachar/">Victoria Nachar</a> <a href="/jayinabox/">Jared Matya</a> 
#HOPA2025
WolverHeme (@wolverheme) 's Twitter Profile Photo

Check out are latest episode, with a star-studded cast! 🤩 "Dex and the Cytokine City: Managing CRS with Bispecifics" #leusm #lymsm #myeloma #TwitteRx @berninini James Davis, PharmD, BCOP Victoria Nachar Anthony Perissinotti Justine Preedit creators.spotify.com/pod/show/wolve…